Novel maxi-k channel blockers, methods of use and process for making the same

Details for Australian Patent Application No. 2003247533 (hide)

Owner Merck & Co., Inc.

Inventors McManus, Owen B.; Garcia, Maria L.; Tkacz, Jan S.; Strohl, William R.; Kaczorowski, Gregory J.; Monaghan, Richard L.; Goetz, Michael A.

Agent Spruson & Ferguson

Pub. Number AU-B-2003247533

PCT Number PCT/US03/18842

PCT Pub. Number WO2003/105724

Priority 60/389,222 17.06.02 US

Filing date 13 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 18 September 2008

International Classifications

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/5575 (2006.01)

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 491/18 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/20 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07J 73/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

C12R 1/66 (2006.01)

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 60/389,222 17.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003247533

18 September 2008 Application Accepted

  Published as AU-B-2003247533

22 January 2009 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247534-A MULTI-CHAMBERED PERSONAL SURVIVAL DEVICE AND AN ORALLY INFLATED, FLUSH MOUNTED, HYBRID BLADDER

2003247532-Systems and methods for constructing genomic-based phenotypic models